Cargando…
Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
Frontotemporal dementia (FTD) is a neurodegenerative disease, leading to behavioral changes and language difficulties. Heterozygous loss-of-function mutations in progranulin (GRN) induce haploinsufficiency of the protein and are associated with up to one-third of all genetic FTD cases worldwide. Whi...
Autores principales: | Terryn, Joke, Verfaillie, Catherine M., Van Damme, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343103/ https://www.ncbi.nlm.nih.gov/pubmed/34366786 http://dx.doi.org/10.3389/fnmol.2021.713031 |
Ejemplares similares
-
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
por: Terryn, Joke, et al.
Publicado: (2018) -
Another piece in the progranulin puzzle: special binding between progranulin and prosaposin creates additional lysosomal access: An Editorial Comment for ‘The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C’ on page 236
por: Van Damme, Philip
Publicado: (2017) -
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia
por: Raitano, Susanna, et al.
Publicado: (2014) -
Metabolic Mechanisms Connecting Alzheimer’s and Parkinson’s Diseases: Potential Avenues for Novel Therapeutic Approaches
por: Colca, Jerry R., et al.
Publicado: (2022) -
New Therapeutic Avenues of mCSF for Brain Diseases and Injuries
por: Pons, Vincent, et al.
Publicado: (2018)